Crawford Investment Counsel Inc. lessened its position in Cardinal Health, Inc. (NYSE:CAH – Free Report) by 41.5% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 238,680 shares of the company’s stock after selling 169,334 shares during the quarter. Crawford Investment Counsel Inc.’s holdings in Cardinal Health were worth $49,049,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Aventura Private Wealth LLC acquired a new stake in Cardinal Health in the 4th quarter valued at approximately $25,000. University of Texas Texas AM Investment Management Co. acquired a new stake in Cardinal Health in the 4th quarter valued at approximately $26,000. Bank of Jackson Hole Trust acquired a new stake in Cardinal Health in the 4th quarter valued at approximately $27,000. Palladiem LLC acquired a new stake in Cardinal Health in the 4th quarter valued at approximately $28,000. Finally, Elyxium Wealth LLC acquired a new stake in Cardinal Health in the 4th quarter valued at approximately $34,000. Institutional investors and hedge funds own 87.17% of the company’s stock.
Analysts Set New Price Targets
A number of brokerages recently issued reports on CAH. Robert W. Baird set a $248.00 target price on Cardinal Health in a research report on Friday, May 1st. Barclays raised their price target on Cardinal Health from $243.00 to $258.00 and gave the company an “overweight” rating in a research note on Tuesday, February 24th. Evercore decreased their price target on Cardinal Health from $260.00 to $240.00 and set an “outperform” rating for the company in a research note on Wednesday, April 8th. Citigroup decreased their price target on Cardinal Health from $249.00 to $245.00 and set a “buy” rating for the company in a research note on Friday, May 1st. Finally, Weiss Ratings downgraded Cardinal Health from a “buy (b+)” rating to a “buy (b)” rating in a research note on Tuesday, May 19th. Fourteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $246.93.
Cardinal Health Stock Up 0.5%
CAH stock opened at $227.63 on Wednesday. The business has a 50 day moving average price of $203.74 and a two-hundred day moving average price of $209.02. The company has a market cap of $53.31 billion, a price-to-earnings ratio of 34.81, a P/E/G ratio of 1.24 and a beta of 0.52. Cardinal Health, Inc. has a twelve month low of $137.75 and a twelve month high of $233.60.
Cardinal Health (NYSE:CAH – Get Free Report) last posted its quarterly earnings results on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, beating analysts’ consensus estimates of $2.79 by $0.38. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The firm had revenue of $60.94 billion during the quarter, compared to the consensus estimate of $62.10 billion. During the same period last year, the company earned $2.35 earnings per share. The business’s revenue was up 11.0% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, equities research analysts anticipate that Cardinal Health, Inc. will post 10.76 EPS for the current fiscal year.
Cardinal Health Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be paid a dividend of $0.5158 per share. The ex-dividend date is Wednesday, July 1st. This represents a $2.06 annualized dividend and a dividend yield of 0.9%. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s dividend payout ratio is presently 31.19%.
Cardinal Health Profile
Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.
The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.
Further Reading
- Five stocks we like better than Cardinal Health
- Gravity Check: Houston, SpaceX Has a Valuation Problem
- Strategy’s Bitcoin Rally Has a Hidden Engine
- Okta’s AI Moment May Be Bigger Than Investors Realize
- 3 Rate-Ready Stocks for the New Fed Chair’s First Big Test
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH – Free Report).
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.
